Clinical Trials Browser

Completed × OTHER × Progression Free Survival × Clear all

NCT03769935 2023-03-29

Maintenance Therapy for Small-cell Lung Cancer

Phase 2 Completed

Progression Free Survival

NCT02959749 2018-02-14

Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer

Phase 2/3 Completed

Progression Free Survival